chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got the vaccine, by 6:00 he was running a little bit of fever, and took some Tylenol and took some more and went to bed with a little headache and a little fever.  The next morning he woke up with a little headache, and by that evening his stomach started aching up, having diarrhea, throwing up and bones/joints and muscles were aching and felt tired.  He continued to take the Tylenol.  By dark Saturday evening he was getting better.  By Sunday evening he was feeling pretty good again other than feeling a little weak, 3/28/21.  He continued to feel week for 2-3 more days, but then was fine.  He did call his doctor on Monday to let him know whether he should take the shot or not, which he did today, 4/23/21.
Notice on next day.  Had bodyaches, general malaise with headache. Arm with redness, swelling, painful and warm to touch. No hives or vesicle, no discharges. Examined by Dr, diagnosed with Cellulitis, allergic reaction and prescribed with Keflex.
My lips started having a burning sensation as of i have eaten some spicy sauce and the sauce is giving my lips have a mild burning feeling.   I haven't eaten anything or done anything out of the ordinary prior to or after my vaccine shot.  Since the vaccine is the only thing different in my life and it has been a few weeks i thought it was the only common denominator that would be causing this feeling.  it doesn't affect anything in my daily life other than a bit of an annoyance to constantly feel this.
Pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Admission for open fracture of proximal end of right tibia.  Procedure(s) - Right - debridement and irrigation of open fracture, open reduction internal fixation of bicondylar tibial plateau fracture. The hospitalization was necessary for pain control, therapy, medical care and discharge placement. Ultimately, the patient was discharged to group home under satisfactory medical and post-operative condition. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Administered varicella on 4/26/2023  varicella expired on 4/16/2023 no s/s pd adverse reaction reported at this time
Information was received on 15-OCT-2015 from a 32 year old female patient consumer reporting on herself. The patient reported that she received her first dose of PNEUMOVAX 23 (dose and injection site not specified) 10 years ago when she was 32 years old. The patient is now 42 years old and on an unknown date, she received a booster shot of the vaccine. No adverse effects were reported. The patient did not wish to provided any additional information. Additional information is not expected. No contact details were provided.
Broke out 7 poxs on back upper arm (rash) saw doctor on Monday 8-20-07. Prescribed Valtrex for a week.
no further AE; pt received an expired dose of Varivax; This spontaneous report was received from a medical assistant to a patient of unknown gender and age. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 09-FEB-2021, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) 1 injection, lot # S002396, expiration date 23-JAN-2021 (dose and route of administration were not provided) for prophylaxis.No adverse events were reported.
?Moderna arm? reaction on right arm. Swollen, lump under arm that started small but grew bigger. Currently a little smaller than a golfball but has grown baseball sized when scratched or touched. It?s hot to the touch and has a red rash about the size of an orange. It?s itchy and burns
Swelling in armpits and arms; Swelling of hands; Swelling in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling in armpits and arms), PERIPHERAL SWELLING (Swelling of hands) and VACCINATION SITE SWELLING (Swelling in the injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history information was reported .  Concomitant products included METFORMIN for an unknown indication.    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced SWELLING (Swelling in armpits and arms), PERIPHERAL SWELLING (Swelling of hands) and VACCINATION SITE SWELLING (Swelling in the injection site). At the time of the report, SWELLING (Swelling in armpits and arms), PERIPHERAL SWELLING (Swelling of hands) and VACCINATION SITE SWELLING (Swelling in the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Pt is 64 Had viral type pneumoia with out pos Covid test in January  2021.   She was left oxygen dependent at 2 liters of oxygen by NC.   on the 14th of April she recieved her second Moderna Covid shot.  Two days later she was begining to become very short of breath.  Needed to turn up her oxygen.  Paramedics came to her house and found that  O2 sat on RA was 60.   In my Emergency room her O2 sat was only 87 percent on her two liters and  on 15 liters of oxygen she was only 94 Percent.
COVID-19; COVID-19; FACILITATED COLLECT  This is a solicited report based on information received by Pfizer from a Facilitating Company. A contactable consumer (patient) reported that a 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), intramuscular on an unspecified date as single dose for COVID-19 immunisation; adalimumab (HUMIRA), subcutaneous from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at unspecified dose (reported as CF) for moderate to severe hidradenitis suppurativa. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced COVID-19. Pfizer Biontech COVID-19 Vaccine (Tozinameran) was also considered suspect. The action taken in response to the events for adalimumab was unknown. The outcome of the events was not recovered.  Causality of COVID-19 and adalimumab as per reporter (Drug/Vaccine) was not reported. Causuality of COVID-19 and BNT162B2 as per reporter (Drug/Vaccine) was Possible.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on the available information and a possible contributory role of suspect product BNT162B2 to the development of event covid19 and drug ineffective cannot be totally excluded.
Gave Novartis H1N1 vaccine (4yrs and older) 0.5ml IM. Should have given Sanofi Pasteur H1N1 vaccine (6 months and older) 0.5ml IM. No signs and symptoms distress noted.
First 48 hours reports felt fine. Sunday am felt achy and tired. Took advil and aspirin. Reports the next 8 days she felt sleepy and achy. Reports felt ok couple of days. Friday 3/5/2021 she had a fever, loss of appetite, chills, for 24 hours. Sunday night had trouble breathing SOB. used humidifier. Chest felt tight. minor cough, symptoms similar to asthma.
Vaccine provided by facility unable to get LOT number and which dose was given in the series. Complains of arm pain several hours later. Ibuprofen administered for localized reaction, additionally mild alergic reaction occured. It is unknown whether the mild reaction was from the ibuprofen or vaccine.
Immediately after injection of the shingles vaccine in left arm, my left hand got pins and needles in it as if it were asleep. This lasted only until I walked out of the store and to my car. A Red Raised Warm Welt appeared about 2" x 2" in size along with a marble sized lump. Perfectly Normal according to papers I received. However, by 48 HRS later, this Red Raised Warm Welt grew to be 3" wide x 4" long and the lump grew to be golf ball size. I put my Nicoderm Patch on the other arm and I Went back to the Pharmacist who advised me to use Maximum Strength anti-itch ointment (1% hydrocortisone). That evening, the lump grew to Baseball size but the ointment was working on the itching. Each day it seems to be a lighter shade of red and today's date, the lump is returned to marble size.
arm pain/same symptoms; a little bit of a fever; fatigue; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain/same symptoms), PYREXIA (a little bit of a fever), FATIGUE (fatigue) and MYALGIA (body aches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain/same symptoms), PYREXIA (a little bit of a fever), FATIGUE (fatigue) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN SODIUM (IBUPROFEN [IBUPROFEN SODIUM]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm pain/same symptoms), PYREXIA (a little bit of a fever), FATIGUE (fatigue) and MYALGIA (body aches) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No  concomitant medication provided by the reporter.   This case was linked to MOD-2021-279498 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: Follow up received, includes no new information.
Pt woke up, room spinning, sat on edge of bed, went to bathroom, felt nauseaus, never vomited, had very mild headache.
This spontaneous report as received from a pharmacist refers to her friends of unknown age. On an unknown date her friends were vaccinated with ZOSTAVAX (lot#, expiration date, dose and route not reported). The pharmacist stated that "her friends experienced redness and swelling" after receiving ZOSTAVAX on an unknown date. The outcome of the events was unknown. It was unspecified if the patients had sought medical attention. Additional information is not expected
pt recvd vax; paresthesia rt arm & edema of tongue immediately; BP 205/110; dx angiodema; rx decadron IM stat & prednisone PO next wk; BP down next day;
2nd dose Moderna was given 8 days too early.  Pt stated he wanted to have the vaccine earlier b/c he had a speaking engagement and was going to be out of town for his assigned 2nd dose return date of 04/04/2021.  Pt called the Call Center and was given a new date (03/27/21) for  his 2nd dose of Moderna. Pt states that the Call Center staff person did not ask what vaccine he was given nor the date of his first dose.  In addition, the extern who administered the dose did not double check to see when the first dose was given and only realized it after having given him the 2nd dose.
Rotarix given IM instead of orally; This case was reported by a nurse via call center representative and described the occurrence of inappropriate route of vaccination in a 4-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number AB3BR, expiry date 29th June 2023) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 23rd November 2021, the patient received the 2nd dose of Rotarix lyophilized formulation (intramuscular) and Rotarix Oral Applicator Device. On 23rd November 2021, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate route of vaccination. On an unknown date, the outcome of the inappropriate route of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The nurse reported that patient received Rotarix dose by intramuscular route by error instead of oral route which led to incorrect route of vaccine administration. The nurse consented to follow up. This case had been linked with case US2021241786, reported by the same reporter for the twin patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021241786:same reporter. Male twin case.
Missed window for second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed window for second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PAIN (Epidural shot for (chronic pain)).    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed window for second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed window for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-039278 (Patient Link).; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot #: Unknown) with no associated AEs.
covid-19; covid-19; This is a literature report for the following literature source(s).  A 40-year-old female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "obesity" (ongoing); "chronic kidney disease" (ongoing); "hypertension" (ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: Nasopharyngeal swab: Positive, notes: testing positive for SARS-CoV-2 by home nasal antigen test. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: As there is limited information in the case provided, the causal association between the Reported events and the suspect drug cannot be excluded. The case will be reassessed once new information is available.,Linked Report(s) : US-PFIZER INC-202200910723 Same patient;
pt recv vax 18AUG97 & 19AUG97 pt exp pain, fever & gen rash which persisted;
Patient had a delayed reaction she was in the parking lot after 30-40 minutes from receiving the moderna shot and she started having hives, threw up, and had massive headache. She had epi-pen injected into her leg and ems was called and came to pick her up after about 20 minutes from epi-pen injection.
after sitting "it was hard to walk"; took a while for my heart to kick in/"heart was slow to kick in; respiration was a challenge; very tired/had to lie down/slept for 3 hours/legs tired easily; loss of energy; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (after sitting "it was hard to walk"), HEART RATE DECREASED (took a while for my heart to kick in/"heart was slow to kick in), RESPIRATION ABNORMAL (respiration was a challenge), ASTHENIA (loss of energy) and FATIGUE (very tired/had to lie down/slept for 3 hours/legs tired easily) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Amyloidosis, Chronic heart failure, Kidney failure and Dialysis. Concurrent medical conditions included Drug allergy (allergic to NsAIDS). Concomitant products included MIDODRINE HCL and ISOSORBIDE for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced ASTHENIA (loss of energy). On 01-Feb-2021, the patient experienced GAIT DISTURBANCE (after sitting "it was hard to walk"), HEART RATE DECREASED (took a while for my heart to kick in/"heart was slow to kick in), RESPIRATION ABNORMAL (respiration was a challenge) and FATIGUE (very tired/had to lie down/slept for 3 hours/legs tired easily). At the time of the report, GAIT DISTURBANCE (after sitting "it was hard to walk"), HEART RATE DECREASED (took a while for my heart to kick in/"heart was slow to kick in), RESPIRATION ABNORMAL (respiration was a challenge), ASTHENIA (loss of energy) and FATIGUE (very tired/had to lie down/slept for 3 hours/legs tired easily) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
The patient's parents reported the patient had a rash all over his body along with a fever for 2-3 days after vaccines were given at 4 month intervals. The patient was treated with Tylenol. The rash disappeared after 3 days.
I GAVE MMR IN HER RIGHT ARM SQ AND ABOUT 2 MINUTES LATER SHE DEVEOLPED A QUARTER SIZE WELP BELOW THE SITE. BENEDRYL WAS GIVEN AND WAS WATCHED IN OUR CLINIC FOR 15 MINUTES AND WAS DOING FINE THE SWOLLEN AREA WAS HALF THE SIZE IT WAS. Follow-up Information 20-AUG-2008: SHE HAD SHOTS TWO DAYS AGO AND HAD A REACTION ON HER ARM WHICH I REPORTED AND NOW THIS MORNING MOM CALLED AND SAID HER RIGHT LEG IS SWOLLEN AND HOT. SHE RECIEVED PEDIARIX AND HEP A IN THAT LEG AND I TOLD HER TO BRING HER TO THE CLINIC FOR AN APPT. PER THE NURSE PRACTITIONER THAT SEEN HER IT IS AN ALLERGIC REACTION.
Pain and redness in lower legs. Swollen ankles later the next day treated by family doctor as cellulitis. Put on Antibiotic.
After receiving the vaccine i just felt pain on my right arm. Took 600mg of ibuprofen around 8:30pm and went to bed. Upon waking up the next morning (today) at 7am, I felt very weak. I ate breakfast by 8am and head to work. The weakness persisted, by 10am when I went to the restroom I felt as if i was going to collapse from how weak I felt while standing.  Felt some chills as if my chest was breathing in cold air. By 10:40am I was home in bed resting. Had a moderate headache and chills, weakness persisted. At 12:50pm I had  a fever of 100.9 F. I drank water, took 600mg ibuprofen and ate an orange. Around 2pm I felt strong enough to get up and take a short walk. At 3:00pm my temperature was 99.8 F, chills were gone. Weakness had improved. No more headache.  At 4:45pm temperature at 99.2 F. And feeling better. I took lunch around 3pm
UNEXPECTED THERAPEUTIC BENEFIT; DULL ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On MAR-2021, the subject experienced unexpected therapeutic benefit. On MAR-2021, the subject experienced dull ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dull ache on MAR-2021, and the outcome of unexpected therapeutic benefit was not reported. This report was non-serious.
Pt brought in by family related fevers and generalized weakness. Treated with dexamethasone and remdesvir. Pt discharged to a snf.
itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported..   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up was received. Event outcome was updated to recovered/resolved.
At approximately 1242 PM administered MenQuadfi into Right deltoid. Patient was alert and oriented at time of administration. Approximately 30-60 seconds after administration patient states he was not feeling well and became unresponsive, pale, never lost a pulse, patient regained consciousness, reported still not feeling well. Patient mother at bedside, EMS contacted at 1245 PM, paramedics arrived shortly after. Obtained Vitals signs initially Temp- 98.4, O2 98%, heart rate 64. After EMS arrived Blood pressure stable 122/75, heart rate 55-64, O2 98%. ECG performed by EMS who recommended patient be transported to "ER due to early repolarization of ST segments." Parent and patient declined recommendation. Patient walked out of clinic alert and oriented, stable with mother and states " feeling much better".   Patient and mother both declined ER visit for further evaluation and states that they will definitely go to ER if any concerns arise hereon after.
This spontaneous report as received from a physician refers to a patient who received both PROQUAD (Merck), 0.5 ml, subcutaneously and VARIVAX (Merck), 0.5 ml, subcutaneously on 02-AUG-2013. No adverse effect reported. Additional information has been requested.
Our daughter began having bone pain around 9 p.m. She threw up approx 11 p.m. Through the night, she began to develop a fever 101.9. Around 5 p.m she said something was wrong over and over. We got ready to go to ER. She wanted to go to bathroom and throw up. When she did, she had a grand mal seizure. My husband had to begin CPR. Fire Rescue team arrived and transported to ER. She was treated and released. Follow up with cardiologist, primary care, and neurologist.
About 22 hours after the shot, I had a mini stroke that required going to the emergency room by ambulance.  I was transported that evening to the stroke  division that same evening for further evaluation, tests and care.  I have never had a mini stroke before this.The doctors said it may have been from the vaccination, or it may not have been precipitated by it.  They said they don't have enough information on the Moderna vaccine to make that call.
Increasing  tenderness and lump in the back of my right arm at the injection site 2 weeks following the first injection.
Hives on back, scalp, face, arm, chest and ears. Began on second day after shot. Took 150mg benadryl 5 days until hives did not reoccur.
Bag error at pharmacy window led to patient receiving Flucelvax instead of Fluad.
pt recv vax & devel rt facila weakness 4OCT96, 3 days;went to ER & dx w/Bell's palsy;
Severe chills, fever, severe muscle pain all over body, headache, dizziness and nausea